Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Tachydysrhythmias, Emergency Medicine


Basics


Description


  • Any disturbance of the hearts rhythm resulting in a rate >100 bpm
  • Sinus tachycardia:
    • Narrow complex regular rhythm at a rate of 100 " “150 bpm
    • Max. rate typically 220 minus age
    • Functional response to physiologic stress caused by increased catecholamine tone or decreased vagal stimulation
  • Supraventricular tachycardia (SVT):
    • A narrow complex tachycardia that originates above the His bundle
  • Regular SVT:
    • Atrial tachycardia
    • Junctional tachycardia:
      • Regular tachycardia without preceding depolarization waves
  • Irregular SVT:
    • Atrial fibrillation (AF)
    • Atrial flutter
    • Multifocal atrial tachycardia
  • Ventricular tachycardia (VT):
    • ≥3 consecutive ventricular ectopic beats at a rate of 100 bpm
    • Most common initiating rhythm in sudden death in patients with previous MI
  • Torsades de pointes:
    • Paroxysmal form of VT with undulating axis and prolonged baseline QT interval
    • Secondary to either congenital or acquired abnormalities of ventricular repolarization
    • Often the result of drug therapy or electrolyte disturbances
  • VF:
    • Oscillations without evidence of discrete QRST morphology
    • Accounts for 80 " “85% of sudden cardiac deaths
    • Frequently results from degeneration of sustained VT

Etiology


  • Sinus tachycardia:
    • Acute MI
    • Anemia
    • Anxiety
    • CHF
    • Drug intoxication
    • Hyperthyroidism
    • Hypovolemia
    • Hypoxia
    • Infection
    • Pain
    • Pericardial tamponade
    • Pulmonary embolus
  • Atrial tachycardia:
    • Precipitated by a premature atrial or ventricular contraction
    • Electrolyte disturbances
    • Drug toxicity
    • Hypoxia
  • Junctional tachycardia:
    • AV nodal re-entry
    • Myocardial ischemia
    • Structural heart disease
    • Pre-excitation syndromes
    • Drug and alcohol toxicity
  • AF:
    • HTN
    • Coronary artery disease
    • Hyper-/Hypothyroidism
    • Alcohol intake
    • Mitral valve disease
    • Chronic obstructive pulmonary disease
    • Pulmonary embolus
    • Wolf " “Parkinson " “White (WPW) syndrome
    • Hypoxia
    • Digoxin toxicity
    • Chronic pericarditis
    • Idiopathic AF
  • Atrial flutter:
    • Ischemic heart disease
    • Valvular heart disease
    • CHF
    • Myocarditis
    • Cardiomyopathies
    • Pulmonary embolus
    • Electrolyte abnormalities
    • Recent cardiac surgery
  • Multifocal atrial tachycardia:
    • Hypoxic effects of chronic lung disease
    • Theophylline toxicity
  • VT:
    • Dilated cardiomyopathy
    • Cardiac ischemia
    • Hypoxia
    • Cardiac scarring/fibrosis
    • After cardiac surgery or congenital anomaly repair
    • Digoxin toxicity
    • Long QT syndrome
    • Electrolyte abnormalities
  • Torsades de pointes:
    • Drug toxicity (antiarrhythmic class IA and III agents, antipsychotics, antibiotics, etc.)
    • Hypokalemia
    • Hypomagnesemia
    • Congenital QT prolongation
  • VF:
    • Acute MI (most common)
    • Chronic ischemic heart disease
    • Hypoxia
    • Acidosis
    • Anaphylaxis
    • Electrocution
    • Shock
    • Hypokalemia
    • Initiation of quinidine therapy
    • Massive hemorrhage

Diagnosis


Signs and Symptoms


  • Asymptomatic
  • Palpitations
  • Lightheadedness
  • Dyspnea
  • Diaphoresis
  • Dizziness
  • Weakness
  • Chest discomfort
  • Angina
  • Syncope
  • Prominent neck veins
  • Signs of instability:
    • Hypotension
    • Pulmonary edema
    • Chest pain
    • Mental status changes

History
  • Acute onset of palpitations, lightheadedness, generalized weakness, or shortness of breath
  • Sudden collapse, often preceded for minutes " “hours by chest pain
  • Prior history of cardiac disease common (ischemia, CHF)

Physical Exam
Determine if the patient is hemodynamically stable: ‚  
  • Assess mental status.
  • Assess heart rate.
  • Assess BP: Normal or hypotensive
  • Cardiac exam

Essential Workup


  • ABCs
  • Determination of unstable vs. stable patient
  • Detailed history
  • 12-lead EKG and rhythm strip to categorize the tachycardia

Diagnosis Tests & Interpretation


Lab
Studies should be ordered based on the presentation to evaluate underlying metabolic abnormalities or ischemia. ‚  
Diagnostic Procedures/Surgery
EKG: ‚  
  • SVT:
    • Narrow complex, rate usually 130 " “160
    • Uniformity of polarity and amplitude
    • No P-waves visible
  • AF:
    • Irregular, narrow QRS complex, rate <150 " “170 bpm
  • Atrial flutter:
    • Regular atrial rate, usually >300
    • Beat-to-beat uniformity of cycle length, polarity, and amplitude
    • Sawtooth flutter waves directed superiorly and most visible in leads II, III, aVF
    • AV block usually 2:1, but occasionally greater or irregular
  • Multifocal atrial tachycardia:
    • 3 distinctly different conducted P waves with varying pulse rate intervals
  • VT:
    • QRS >0.12 sec and often >0.14 sec.
  • Torsades de pointes:
    • Wide complex, ventricular rate >200 bpm
    • QRS structure displays an undulating axis, with the polarity of the complexes appearing to shift around the baseline.
    • Occurrence is often in short episodes of <90 sec.
  • VF:
    • EKG shows oscillations without evidence of discrete QRST morphology.
    • Oscillations are usually irregular and occur at a rate of 150 " “300 bpm.
    • When the amplitude of most oscillations is 1 mm, the term "coarse "  is used.
    • "Fine "  VF is used for oscillations <1 mm.

Treatment


Pre-Hospital


Cardiopulmonary resuscitation if pulseless ‚  

Initial Stabilization/Therapy


  • IV access
  • Oxygen
  • Cardiac monitor
  • Determine rhythm

Ed Treatment/Procedures


  • Irregular narrow complex (A fib):
    • Rate control
    • Ž ²-Blockers or calcium channel blockers
    • Anticoagulation if onset is >24 hr
    • Cardioversion for severe hemodynamic compromise
  • Regular narrow-complex tachydysrhythmia:
    • Vagal maneuvers occasionally terminate the dysrhythmia:
      • Beware of carotid disease in elderly.
    • Adenosine:
      • May be diagnostic, revealing underlying AF/atrial flutter
  • Stable wide-complex tachycardia:
    • Determine whether VT or SVT with aberrancy
    • Administration of AV nodal-blocking agents (verapamil, adenosine) may result in VF:
      • With WPW, use amiodarone, flecainide, procainamide, or DC cardioversion.
    • Electrical cardioversion should be utilized when mechanism unknown.
    • Antidysrhythmic drugs include procainamide and amiodarone.
  • Torsades de pointes:
    • Magnesium, overdrive pacing, amiodarone
    • Correct underlying abnormal electrolytes.
    • Consider repletion of serum K to 4.5.
  • Polymorphic VT (variable QRS morphology):
    • Ejection fraction (EF) normal:
      • Ž ²-Blockers, lidocaine, amiodarone, or procainamide
    • EF abnormal:
      • Amiodarone or lidocaine; then synchronized cardioversion
    • Treat ischemia and correct electrolytes.
  • Monomorphic VT:
    • EF normal:
      • Procainamide preferred to amiodarone, sotalol, lidocaine; synchronized cardioversion
    • EF abnormal:
      • Amiodarone or lidocaine
      • Procainamide with caution as may cause hypotension; synchronized cardioversion
  • VF or pulseless VT:
    • Treatment per ACLS protocol

Medication


  • Adenosine: 6 mg (peds: 0.1 mg/kg up to 6 mg) rapid IV push; if no response after 1 " “2 min, then 12 mg (peds: 0.2 mg/kg up to 12 mg), may repeat 12 mg (0.2 mg/kg)
  • Amiodarone:
    • VT/SVT with pulse: 150 mg IV over 10 min (peds: 5 mg/kg IV over 20 " “60 min, redose up to 15 mg/kg, 300 mg max), then 1 mg/min for 6 hr and 0.5 mg/min for next 18 hr.
    • VF/pulseless VT: 300 mg IV push (peds: 5 mg/kg IV), may give 150 mg IV push 3 " “5 min after if no response (peds: redose up to 15 mg/kg or 300 mg max), followed by infusion as above.
  • Diltiazem: 0.25 mg/kg IV (usually 10 " “20 mg) over 2 min, followed in 15 min by 0.35 mg/kg IV over 2 min
  • Epinephrine: 1 mg (peds: 0.01 mg/kg) IV push q3 " “5min; 2.5 mg (peds: 0.1 mg/kg) endotracheally q3 " “5min
  • Lidocaine: 1 " “1.5 mg/kg (100 mg) (peds: 1 mg/kg) IV push, may repeat q5 " “10min, max. dose 3 mg/kg
  • Magnesium sulfate: 2 g diluted in 100 mL D5W IV over 2 min (peds: 25 " “50 mg/kg, max. 2 g, IV over 10 " “20 min)
  • Metoprolol: 5 " “15 mg slow IV push at 5-min intervals to total of 15 mg
  • Procainamide:
    • VF/pulseless VT: 30 mg/min (peds: Not recommended) IV load until rhythm resolves, hypotension, QRS widens >50% or max. 17 mg/kg, then 1 " “4 mg/min IV
    • Perfusing VT: 20 mg/min (peds: 15 mg/kg IV over 30 " “60 min) IV load until rhythm resolves, hypotension, QRS widens >50% or max. 17 mg/kg, then 1 " “4 mg/min IV
    • SVT: 15 " “17 mg/kg IV at 20 " “30 mg/min or 100 mg IV q5min slow IV push until rhythm resolves or max. dose 1,000 mg (peds: 3 " “6 mg/kg IV over 5 min, max. 100 mg/dose, may repeat q5 " “10min as needed to total dose 15 mg/kg)
  • Vasopressin: 40 U (peds: Not recommended) IV push once

Follow-Up


Disposition


Admission Criteria
  • VT or VF
  • Possible cardiac ischemic event
  • Persistent SVT
  • Underlying metabolic abnormalities

Discharge Criteria
Terminated supraventricular rhythm without organ hypoperfusion ‚  
Issues for Referral
Electrophysiologic testing: ‚  
  • Diagnostic but not required emergently
  • Determines therapy for accessory pathways

Pearls and Pitfalls


  • Always suspect a ventricular rhythm with a wide complex rhythm, especially in the older patient.
  • Antidysrhythmic administration may increase success rate of cardioversion.
  • Rapid, uninterrupted chest compressions may increase the success rate of defibrillation for a patient with a pulseless rhythm.

Additional Reading


  • Anderson ‚  BR, Vetter ‚  VL. Arrhythmogenic causes of chest pain in children. Pediatr Clin North Am.  2010;57:1305 " “1329.
  • Hood ‚  RE, Shorofsky ‚  SR. Management of arrhythmias in the emergency department. Cardiol Clin.  2006;24:125 " “133.
  • Link ‚  MS. Clinical practice. Evaluation and initial treatment of supraventricular tachycardia. N Eng J Med.  2012;367(15):1438 " “1448.
  • Neumar ‚  RW, Otto ‚  CW, Link ‚  MS, et al. Part 8: Adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation.  2010;122(18 suppl 3):S729 " “S767.
  • Roberts-Thomson ‚  KC, Lau ‚  DH, Sanders ‚  P. The diagnosis and management of ventricular arrhythmias. Nat Rev Cardiol.  2011;8:311 " “321.

See Also (Topic, Algorithm, Electronic Media Element)


  • Atrial Fibrillation
  • Supraventricular Tachycardia
  • Ventricular Tachycardia

Codes


ICD9


  • 427.0 Paroxysmal supraventricular tachycardia
  • 427.1 Paroxysmal ventricular tachycardia
  • 785.0 Tachycardia, unspecified
  • 427.31 Atrial fibrillation
  • 427.32 Atrial flutter
  • 427.89 Other specified cardiac dysrhythmias

ICD10


  • I47.1 Supraventricular tachycardia
  • I47.2 Ventricular tachycardia
  • R00.0 Tachycardia, unspecified
  • I48.91 Unspecified atrial fibrillation
  • I48.92 Unspecified atrial flutter

SNOMED


  • 6285003 Tachyarrhythmia (disorder)
  • 6456007 Supraventricular tachycardia (disorder)
  • 25569003 Ventricular tachycardia (disorder)
  • 49436004 Atrial fibrillation (disorder)
  • 11092001 Sinus tachycardia (finding)
  • 251165007 atrioventricular junctional (nodal) tachycardia (disorder)
  • 276796006 Atrial tachycardia (disorder)
  • 419166005 Junctional ectopic tachycardia (disorder)
  • 5370000 Atrial flutter (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer